Gustafson, Sally K., MS
Biostatistician"I help investigators do right by their data."
About
Sally Gustafson, MS, is a Biostatistician at Health Partners Institute and a member of the Research Methodology Group. She earned her Masters degree in Statistics from the University of Minnesota, and came to HPI in 2022 with over 12 years of experience in health research. Her areas of expertise are risk-adjusted outcomes and predictive modeling, particularly of organ transplant and end stage renal disease (ESRD) survival data. She has co-authored several papers that leverage national pharmacy clearinghouse databases to describe treatment adherence in those patient populations. Now her work is more prospective, ranging from large, externally funded RCTs to small-scale, proof-of-concept studies of investigative treatments. She has a special interest in disparities in healthcare outcomes and access to healthcare.
Conducting Institute research since 2022.
Education and training: MS, Statistics, University of Minnesota, Minneapolis BS, Mathematics & Psychology, University of Virginia
Research interests include: Predictive modeling Survival analysis Risk adjustment Disparities in access to healthcare Current research activities and funding: GluCoCare: Comparing Fingerstick Blood Glucose Monitoring versus Continuous Glucose Monitoring in Primary Care (PIs: Thomas Martens and Richard Bergenstal)
R33 grant from the National Institute on Aging: A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment (PIs: Rebecca Rossom and Leah Hanson)
The Minnesota Memory Project
Sally Gustafson, MS, is a Biostatistician at Health Partners Institute and a member of the Research Methodology Group. She earned her Masters degree in Statistics from the University of Minnesota, and came to HPI in 2022 with over 12 years of experience in health research. Her areas of expertise are risk-adjusted outcomes and predictive modeling, particularly of organ transplant and end stage renal disease (ESRD) survival data. She has co-authored several papers that leverage national pharmacy clearinghouse databases to describe treatment adherence in those patient populations. Now her work is more prospective, ranging from large, externally funded RCTs to small-scale, proof-of-concept studies of investigative treatments. She has a special interest in disparities in healthcare outcomes and access to healthcare.
Conducting Institute research since 2022.
Education and training: MS, Statistics, University of Minnesota, Minneapolis BS, Mathematics & Psychology, University of Virginia
